Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas

This study has been suspended.

Study NCT00031083 Information provided by Biogen Idec

First Received: February 20, 2002 Last Updated: June 7, 2006 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been suspended.
Estimated Study Completion Date:	March 2004
Estimated Primary Completion Date:	No date given